Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Healthcare Industrials Biotechnology Conglomerates

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of... see more

Add To Watchlist

Recent & Breaking News (TSXV:TELO)

3D Signatures to Present Positive Results for Prostate Cancer Liquid Biopsy

GlobeNewswire February 21, 2017

3D Signatures Inc. Adds Medical Diagnostic Expert to Business Advisory Board

GlobeNewswire February 15, 2017

3D Signatures Inc. to Present at the Noble Financial Capital Markets’ 13th Annual Investor Conference

GlobeNewswire January 25, 2017

3D Signatures Inc. Announces Grant of Stock Options

GlobeNewswire January 18, 2017

3D Signatures Inc. Provides Further Detail on Kilmer Lucas Engagement

GlobeNewswire January 16, 2017

New Study Shows 3D Signatures' Telomere Analysis May Be an Effective Biomarker for Monitoring High Risk Prostate Cancer Patients

MarketWire Canada January 9, 2017

3D Signatures Inc. Announces Closing of Third and Final Tranche of Fully Subscribed Brokered Private Placement

MarketWire Canada January 6, 2017

3D Signatures Appoints Accomplished Healthcare Veteran as Chief Business Officer

MarketWire Canada January 6, 2017

3D Signatures Common Shares Now Listed on the OTCQB and Frankfurt Stock Exchanges

MarketWire Canada January 4, 2017

3D Signatures Inc. Announces Closing of Second Tranche of Brokered Private Placement

MarketWire Canada December 22, 2016

3D Signatures Inc. Announces the Issuance of 5,187,618 Units Pursuant to Its Over-Subscribed $3.9 Million Brokered Private Placement

MarketWire Canada December 16, 2016

3D Signatures Appoints Two Industry Specialists to Board Positions

MarketWire Canada December 9, 2016

3D Signatures Molecular Imaging Technology Shows Potential in Improving Management of Lung Cancer Patients With Multiple Lesions

MarketWire Canada December 7, 2016

3D Signatures Adds Leading Commercial Diagnostics Lab Executive to Advisory Board

MarketWire Canada December 5, 2016

3D Signatures Inc. Announces Brokered Private Placement

MarketWire Canada November 17, 2016

3D Signatures Inc. Introduces Internationally Recognized Clinical and Scientific Advisory Board

MarketWire Canada November 14, 2016

3D Signatures Inc. Opens the Market

Canada NewsWire November 2, 2016

3D Signatures Inc. Announces Grant of Stock Options

MarketWire Canada November 2, 2016

3D Signatures Inc. Introduces Business Advisory Board and Celebrates Recent Listing by Opening Toronto Stock Exchange November 2

MarketWire Canada October 27, 2016

3D Signatures Included in Major Clinical Trial for Prostate Cancer

MarketWire Canada October 19, 2016